Robert S. Fishman is Chief Medical Officer at CORCEPT THERAPEUTICS INC (CORT). They have made 12 open-market trades across 1 company since 2017, most recently 2018-11-07.
CIK 0001232237
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 12 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CORT | 8,000 | $634K |
Shares reported on the most recent Form 4, priced at the 2018-11-09 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CORT | SELL | 2018-11-07 | 2018-11-09 | $13.74 | $110K | -1.4% | +0.3% | -14.7% |
| CORT | SELL | 2018-10-08 | 2018-10-09 | $13.19 | $106K | -11.0% | -2.2% | +1.8% |
| CORT | SELL | 2018-09-07 | 2018-09-11 | $14.57 | $117K | -1.4% | -11.2% | -10.8% |
| CORT | SELL | 2018-08-07 | 2018-08-08 | $14.15 | $113K | -7.8% | +4.7% | -4.7% |
| CORT | SELL | 2018-07-06 | 2018-07-09 | $15.09 | $121K | -14.4% | -8.9% | -13.9% |
| CORT | SELL | 2018-06-07 | 2018-06-11 | $18.23 | $146K | -12.1% | -18.0% | -23.1% |
| CORT | SELL | 2018-05-07 | 2018-05-08 | $17.68 | $141K | +9.8% | +7.6% | -17.7% |
| CORT | SELL | 2018-04-06 | 2018-04-09 | $16.22 | $260K | +6.9% | +0.2% | -9.1% |
| CORT | SELL | 2018-03-07 | 2018-03-08 | $15.67 | $125K | +3.1% | -1.0% | +11.1% |
| CORT | SELL | 2018-02-07 | 2018-02-09 | $16.60 | $133K | +9.0% | +17.9% | +6.8% |
| CORT | SELL | 2018-01-08 | 2018-01-10 | $18.67 | $149K | +23.1% | -29.4% | -18.0% |
| CORT | SELL | 2017-12-08 | 2017-12-12 | $16.72 | $134K | +4.8% | +22.1% | +1.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.